Literature DB >> 18482923

Two-year stability of NT-proBNP in frozen samples using the Roche Elecsys system.

B Cauliez1, J Guignery, S Marinier, I Mariau, A Lavoinne.   

Abstract

BACKGROUND: The in vitro stability of N-terminal (NT)-proBNP (brain natriuretic peptide) at room temperature and at 4 degrees C is excellent and has been well studied. However, less is known concerning its stability after a long-term frozen storage. This notion could be of major interest in the context of clinical evaluations.
METHODS: NT-proBNP was measured on 97 heparinized samples before and after a two-year frozen storage (-20 degrees C) using the Roche Elecsys system.
RESULTS: There is a slight but significant decrease of NT-proBNP concentration after frozen storage. However, this decrease is <10% for more than 90% of the samples and the maximum decrease is 16%. Moreover, values on frozen samples are well correlated with values on fresh samples (r = 0.99) using the following equation: NT-proBNP(stored sample) = 0.93 NT-proBNP(fresh sample) + 81. A similar equation was found in lower concentrations (NT-proBNP < or = 2000 ng/L).
CONCLUSIONS: These data show that NT-proBNP can be stored for at least two years at -20 degrees C before measurement without a substantial loss of immunoreactivity.

Mesh:

Substances:

Year:  2008        PMID: 18482923     DOI: 10.1258/acb.2007.007187

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  11 in total

1.  Elevated natriuretic peptide levels and cognitive function in community-dwelling older adults.

Authors:  Lori B Daniels; Gail A Laughlin; Donna Kritz-Silverstein; Paul Clopton; Wei-Chung Chen; Alan S Maisel; Elizabeth Barrett-Connor
Journal:  Am J Med       Date:  2011-07       Impact factor: 4.965

2.  Glycemic excursions and subclinical cardiac damage in adults with type 2 diabetes: Results from the ADVANCE Trial.

Authors:  Mary R Rooney; Dan Wang; J William McEvoy; Stephen P Juraschek; John Chalmers; Mark Woodward; Elizabeth Selvin
Journal:  Diabetes Res Clin Pract       Date:  2021-11-17       Impact factor: 5.602

3.  Cardiac biomarkers in HIV-exposed uninfected children.

Authors:  James D Wilkinson; Paige L Williams; Erin Leister; Bret Zeldow; William T Shearer; Steven D Colan; George K Siberry; Laurie B Dooley; Gwendolyn B Scott; Kenneth C Rich; Steven E Lipshultz
Journal:  AIDS       Date:  2013-04-24       Impact factor: 4.177

4.  Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing.

Authors:  Christopher R deFilippi; Robert H Christenson; John S Gottdiener; Willem J Kop; Stephen L Seliger
Journal:  J Am Coll Cardiol       Date:  2010-02-02       Impact factor: 27.203

5.  Elevated NT-pro-brain natriuretic peptide level is independently associated with all-cause mortality in HIV-infected women in the early and recent HAART eras in the Women's Interagency HIV Study cohort.

Authors:  Matthew R Gingo; Yingze Zhang; Kidane B Ghebrehawariat; Jong-Hyeon Jeong; Yanxia Chu; Quanwei Yang; Lorrie Lucht; David B Hanna; Jason M Lazar; Mark T Gladwin; Alison Morris
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

6.  Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes.

Authors:  Sara J Jenks; Bryan R Conway; Stela McLachlan; Wei Leng Teoh; Rachel M Williamson; David J Webb; Paul Welsh; Naveed Sattar; Mark W J Strachan; Jackie F Price
Journal:  Diabetologia       Date:  2017-05-20       Impact factor: 10.122

7.  Urinary N-terminal pro-B-type natriuretic peptide as a biomarker for cardiovascular events in a general Japanese population: the Hisayama Study.

Authors:  Keisuke Yamasaki; Jun Hata; Tomomi Ide; Takuya Nagata; Satoko Sakata; Daigo Yoshida; Takanori Honda; Yoichiro Hirakawa; Toshiaki Nakano; Takanari Kitazono; Hiroyuki Tsutsui; Toshiharu Ninomiya
Journal:  Environ Health Prev Med       Date:  2021-04-12       Impact factor: 3.674

8.  N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS.

Authors:  Paul Welsh; Orla Doolin; Peter Willeit; Chris Packard; Peter Macfarlane; Stuart Cobbe; Vilmundur Gudnason; Emanuele Di Angelantonio; Ian Ford; Naveed Sattar
Journal:  Eur Heart J       Date:  2012-08-31       Impact factor: 29.983

9.  The effect of surgical and non-surgical weight loss on N-terminal pro-B-type natriuretic peptide and its relation to obstructive sleep apnea and pulmonary function.

Authors:  Anne-Marie Gabrielsen; Torbjørn Omland; Mette Brokner; Jan Magnus Fredheim; Jens Jordan; Sverre Lehmann; May Brit Lund; Jøran Hjelmesæth; Dag Hofsø
Journal:  BMC Res Notes       Date:  2016-09-13

10.  N-Terminal Pro Brain, N-Terminal Pro Atrial Natriuretic Peptides, and Dynamic Cerebral Autoregulation.

Authors:  Simin Mahinrad; Behnam Sabayan; Chaney R Garner; Donald M Lloyd-Jones; Farzaneh A Sorond
Journal:  J Am Heart Assoc       Date:  2020-10-16       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.